Delivery Order SPE2DB22D2005-SPE2DB25FJRW2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $33,063.14, represents a non-set-aside competitive award and is scheduled for ultimate completion by August 8, 2025. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $31,897.20 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. The award was issued without a set-aside designation and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order valued at $45,836.39 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count) valued at $6,601.92. This non-competitive, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Concerta ER (Extended Release) tablets 36 mg. This firm fixed-price delivery order, valued at approximately $42.9K, represents a non-competitive award under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The contract is scheduled for completion by August 1, 2025, with fulfillment occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $15,944.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,745.29 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction fulfilling federal medical procurement requirements. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRW2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a contract value of $10,721.06. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of August 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, maintaining an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. This delivery order for methylphenidate extended-release tablets supports the medical supply chain serving military personnel and veterans through the DLA's established pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/15/25 |